History
October 2023
August 2025
Established with the aim of commercializing ICS
Company Profile
Company name: CellFold, Inc.
Established August 5, 2025
Capital: 1 million yen
CEO: Kenichi Yamahara
Business activities: Manufacturing of regenerative medicine products and medical devices, scientific research and technical services.
Director: Nobuo Kanai
Yasumichi Kogai
Auditor: Kenji Okuzono
Technical Advisor: Tsutomu Furuzono (Professor, Kindai University)
Medical Advisor: Shinya Fukumoto (Associate Professor, Osaka Municipal University School of Medicine)
Intellectual Property Advisor: Hideki Takeda (President and CEO of Medical Patent Research Co., Ltd.)
Contact Us
TEL: 050-1342-1564
Email: info[at]cellfold.jp
Tokyo Headquarters
〒104-0061
N&E BLD. 6F, 1-12-4 Ginza, Chuo-ku, Tokyo
Kansai Headquarters
〒663-8501
1-1 Mukogawa-cho, Nishinomiya City, Hyogo Prefecture
Department of Molecular and Cellular Therapy, Institute for Advanced Medical Research, Hyogo College of Medicine